Imunon, Inc. (IMNN)
1.28
-0.04
(-3.03%)
USD |
NASDAQ |
Oct 02, 16:00
1.28
0.00 (0.00%)
After-Hours: 20:00
Imunon Net Income (Quarterly) : -2.814M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.814M |
| March 31, 2026 | -4.249M |
| December 31, 2025 | -4.223M |
| September 30, 2025 | -3.429M |
| June 30, 2025 | -2.741M |
| March 31, 2025 | -4.102M |
| December 31, 2024 | -4.057M |
| September 30, 2024 | -4.846M |
| June 30, 2024 | -4.788M |
| March 31, 2024 | -4.930M |
| December 31, 2023 | -4.888M |
| September 30, 2023 | -3.477M |
| June 30, 2023 | -5.559M |
| March 31, 2023 | -5.591M |
| December 31, 2022 | -13.23M |
| September 30, 2022 | -6.148M |
| June 30, 2022 | -6.043M |
| March 31, 2022 | -10.47M |
| December 31, 2021 | -4.221M |
| September 30, 2021 | -5.410M |
| June 30, 2021 | -5.448M |
| March 31, 2021 | -5.689M |
| December 31, 2020 | -3.012M |
| September 30, 2020 | -8.072M |
| June 30, 2020 | -5.343M |
| Date | Value |
|---|---|
| March 31, 2020 | -5.057M |
| December 31, 2019 | -3.103M |
| September 30, 2019 | -5.477M |
| June 30, 2019 | -5.904M |
| March 31, 2019 | -2.368M |
| December 31, 2018 | 5.481M |
| September 30, 2018 | -4.656M |
| June 30, 2018 | -8.231M |
| March 31, 2018 | -4.477M |
| December 31, 2017 | -4.681M |
| September 30, 2017 | -5.671M |
| June 30, 2017 | -5.236M |
| March 31, 2017 | -5.160M |
| December 31, 2016 | -5.397M |
| September 30, 2016 | -6.410M |
| June 30, 2016 | -4.531M |
| March 31, 2016 | -5.716M |
| December 31, 2015 | -5.514M |
| September 30, 2015 | -4.267M |
| June 30, 2015 | -5.675M |
| March 31, 2015 | -7.005M |
| December 31, 2014 | -6.456M |
| September 30, 2014 | -6.942M |
| June 30, 2014 | -6.673M |
| March 31, 2014 | -5.423M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Agenus, Inc. | -0.567M |
| Amgen, Inc. | 2.375B |
| BioCryst Pharmaceuticals, Inc. | 78.40M |
| Curis, Inc. | -8.581M |
| CEL-SCI Corp. | -5.668M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 2.814M |
| EPS Diluted (Quarterly) | -0.5412 |
| Enterprise Value | 6.953M |
| Earnings Yield | -300.2% |
| Normalized Earnings Yield | -300.45 |